27 Aug 2013

Transatlantic Partnership brings Outcome Based Analytics to UK Healthcare

AbedGraham Healthcare Strategies today announces its commercial partnership with California’s SyTrueTM to bring their clinical data analytics service to the UK. The SyTrueTM system’s ability to identify patterns in unstructured healthcare data has already been associated with significant cost savings, in excess of £1.2million ($2million), and continues to be extensively piloted in the United States.

This will be SyTrueTM’s first major global expansion beyond the United States. 

“The NHS generates overwhelming amounts of data every day the analysis of which is critical to driving improved clinical and financial decision making,” comments Dr Alexander Graham, founding partner at AbedGraham. 

Kyle Silvestro, founder and CEO of SyTrueTM explains, “Healthcare is part of everyone's life, it's a very large target market all around the world. But interestingly enough, in this whole new digital data revolution, there is no market leader. No one has found the recipe for digital documentation. We’ve found the recipe and we’re excited to bring it to the UK.” 

SyTrueTM’s products are available both for pilot testing and procurement through AbedGraham. For more details contact Dr Alexander Graham at [email protected]

About

AbedGraham Healthcare Strategies Ltd www.abedgraham.com

AbedGraham is a transatlantic market access and business development consultancy supporting the adoption of clinically oriented digital and mobile technologies. Founded by a pair of graduates from Cambridge and Imperial College London the team is uniquely composed of medical doctors with commercial experience offering unparalleled insights into what is required to develop successful healthcare technology. 

SyTrueTM Inc. www.sytrue.com

SyTrueTM's platform as a service (PaaS) is reinventing clinical documentation while revolutionising expectations around data usability and interoperability. SyTrueTM's clinical analytics allows health systems, physician groups, clinical researchers and pharmaceutical companies to mine their multi-sourced clinical data and, in short, create longitudinal records of patient populations, usable in seconds